Clinical Trials in Canberra, Australian Capital Territory

Find clinical trials in Canberra, Australian Capital Territory. Discover local research opportunities and treatment options in your area.

21 Active Trials Found in Canberra

Showing 21 trials on this page

Page 1 of 2

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT ID: NCT06360094

This clinical trial is looking at a new medication called BI 1839100 to see if it can help reduce coughing in adults with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF)...

Recruiting

Phase: PHASE2 Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT06508658

This clinical trial is studying a new combination treatment for adult patients with diffuse large B-cell lymphoma (DLBCL), a type of aggressive cancer affecting immune cells. Researchers want to se...

Recruiting

Phase: PHASE3 Conditions: Diffuse Large B-Cell Lymphoma

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

NCT ID: NCT05648968

This clinical trial is studying a new treatment called ianalumab for patients with a condition known as warm autoimmune hemolytic anemia (wAIHA). This condition causes the body to destroy its own r...

Recruiting

Phase: PHASE3 Conditions: Warm Autoimmune Hemolytic Anemia (wAIHA)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT ID: NCT06875310

The KRYSTAL-4 trial is studying a new treatment approach for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has a mutation known as KRAS G12C. This tria...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT ID: NCT05653349

This clinical trial is studying a medication called ianalumab to see how well it works in helping adults with a condition called primary immune thrombocytopenia (ITP) maintain a healthy platelet co...

Recruiting

Phase: PHASE3 Conditions: Primary Immune Thrombocytopenia (ITP)

A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT ID: NCT06500702

This clinical trial is studying the effectiveness and safety of three different treatments—frexalimab, SAR442970, and rilzabrutinib—in patients aged 16 to 75 years with specific kidney conditions c...

Recruiting

Phase: PHASE2 Conditions: Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

NCT ID: NCT05263934

This clinical trial is studying a new treatment called depemokimab to see how well it works compared to another treatment called mepolizumab for adults with a condition called Eosinophilic Granulom...

Recruiting

Phase: PHASE3 Conditions: Eosinophilic Granulomatosis With Polyangiitis

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

NCT ID: NCT05325008

The BEAT-BK clinical trial is studying how different treatments can help patients who have had a kidney or simultaneous kidney and pancreas transplant and are experiencing a viral infection called ...

Recruiting

Phase: PHASE3 Conditions: Kidney Transplant Failure and Rejection, Kidney Transplant Infection +1 more

Efficacy and Safety of HB-1 for Panic Disorder

NCT ID: NCT06483789

This clinical trial is studying a new treatment called HB-1 for individuals with Panic Disorder, which is a mental health condition that causes sudden and intense feelings of fear and anxiety. The ...

Recruiting

Phase: PHASE2 Conditions: Panic Disorder, Mental Illness

Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

NCT ID: NCT06782971

This clinical trial is focused on finding new ways to treat patients with Acute Myeloid Leukemia (AML), a type of cancer that affects the blood and bone marrow. Researchers want to see if they can ...

Recruiting

Conditions: AML - Acute Myeloid Leukemia

YN001-004 in Patients With Coronary Atherosclerosis in Australia

NCT ID: NCT06700720

This clinical trial, called YN001-004, is investigating a treatment called YN001 for patients with coronary atherosclerosis, a condition where the arteries that supply blood to the heart become nar...

Recruiting

Phase: PHASE2 Conditions: Coronary Artery Disease, Coronary Atherosclerotic Disease

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

NCT ID: NCT05334368

This clinical trial is studying a new treatment called depemokimab for adults with Hypereosinophilic Syndrome (HES), a condition where the body produces too many eosinophils, a type of white blood ...

Recruiting

Phase: PHASE3 Conditions: Hypereosinophilic Syndrome

Maintenance rTMS for Depression (Maitr-De)

NCT ID: NCT06938841

The Maintenance rTMS for Depression (Maitr-De) clinical trial is studying a treatment called repetitive transcranial magnetic stimulation (rTMS) for people who have major depressive disorder and ha...

Recruiting

Phase: NA Conditions: Major Depressive Disorder, Treatment Resistant Depression

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis

NCT ID: NCT05802264

This clinical trial is investigating a new treatment called Amphotericin B Cystetic for Inhalation (ABCI) to see how safe it is and how well it works in both healthy individuals and people with cys...

Recruiting

Phase: PHASE1 Conditions: Cystic Fibrosis

Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies

NCT ID: NCT04170283

This is a long-term extension study to look at the safety and some outcomes of zanubrutinib (a cancer drug that targets BTK) in people who have B-cell cancers and who took part in a BeiGene parent ...

Enrolling by invitation

Phase: PHASE3 Conditions: B-cell Malignancies

Fibrinolysis Resistance in Infection and Trauma

NCT ID: NCT06680180

This clinical trial, titled "Fibrinolysis Resistance in Infection and Trauma," is focused on understanding blood clotting problems in critically ill patients, particularly those suffering from seve...

Recruiting

Conditions: Trauma, Sepsis and Septic Shock

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

NCT ID: NCT02735707

The REMAP-CAP trial is a research study designed to find out which treatments work best for patients with community-acquired pneumonia, especially those who are very sick and need to be in the inte...

Recruiting

Phase: PHASE3 Conditions: Community-acquired Pneumonia, Influenza, COVID-19

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

NCT ID: NCT05713136

The National Australian HCV Point-of-Care Testing Program is a study aimed at improving how we screen for and treat Hepatitis C, a virus that affects the liver. The researchers want to find out if ...

Recruiting

Conditions: Hepatitis C

The National Australian HCV Point-of-Care Testing Program

NCT ID: NCT05042544

The National Australian HCV Point-of-Care Testing Program is a study aimed at improving the diagnosis and treatment of hepatitis C (HCV), a viral infection that can harm the liver. The researchers ...

Recruiting

Conditions: Hepatitis C

EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer

NCT ID: NCT02889874

This clinical trial is studying a new approach to treating early-stage breast cancer, specifically looking at whether radiation therapy is necessary after surgery for patients with a specific type ...

Recruiting

Phase: NA Conditions: Early Stage Breast Carcinoma